Jennifer Brown, MD, PhD from the Dana-Farber Cancer Institute, Boston, MA outlines the side effects that may occur in chronic lymphocytic leukemia (CLL) patients treated with idealisib and how to manage them. Side effects to look out for include neutropenia, bacterial infections, immunologic toxicitiy and diarrhea colitis.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.